| page | |
| EDITORIALS |
| 1094 | Oral corticosteroid stewardship for asthma: Time to move from theory to routine clinical practice
David Watchorn MB BCh, BAO, MRCPI, Andrew Menzies-Gow BSc, MB BS, PhD, FRCP
10.1111/resp.14171 |
| 1096 | Does COPD start in the nursery?
|
| 1098 | Pulmonary fibrosis associated with telomere-related gene mutations: A complex inheritance
|
| 1101 | COVID-19 hospitalizations: Another adverse impact of ambient air pollution?
|
| COMMENTARIES |
| 1103 | Variations in lung cancer care and outcomes: How best to identify and improve standards of care?
Fraser Brims FRACP, FRCP, MD, Tracy Leong FRACP, MPH, PhD, Emily Stone FRACP, PhD, Susan Harden MRCP, FRCR, DM, Henry Marshall PhD, FRACP, Neal Navani FRCP, PhD, Rob Stirling FRACP, RCPI
10.1111/resp.14155 |
| 1106 | The impact of COVID-19 on acute non-invasive ventilation services: A case for change
Alastair Watson PhD, Hannah Barnard BSc, Pearlene Antoine-Pitterson MSc MCSP, Bethany Jones MSc MCSP, Alice M Turner MRCP PhD, Rahul Mukherjee FRCP (London) FRCP (Edin.) FCCP
10.1111/resp.14156 |
| 1110 | Breathing–swallow dysfunction in COPD: How silent aspiration may be contributing to exacerbations
|
| POSITION STATEMENT |
| 1112 | Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand
John Blakey, Li Ping Chung, Vanessa M McDonald, Laurence Ruane, John Gornall, Chris Barton, Sinthia Bosnic-Anticevich, John Harrington, Mark Hew, Anne E Holland, Trudy Hopkins, Lata Jayaram, Helen Reddel, John W Upham, Peter G Gibson, Philip Bardin
10.1111/resp.14147 |
| SYSTEMATIC REVIEW |
| 1131 | Impact of early life exposures on COPD in adulthood: A systematic review and meta-analysis
Pengfei Duan, Yao Wang, Rongqing Lin, Yiming Zeng, Chengshui Chen, Li Yang, Minghui Yue, Shan Zhong, Yun Wang, Qingying Zhang
10.1111/resp.14144 |
| ORIGINAL ARTICLES |
| Environmental and Occupational Lung Disease |
| 1152 | Physical activity decline is disproportionate to decline in pulmonary physiology in IPF
Jyotika D Prasad, Eldho Paul, Anne E Holland, Ian N Glaspole, Glen P Westall
10.1111/resp.14137
Patients with idiopathic pulmonary fibrosis have low levels of daily physical activity (DPA). The decline in physical activity is larger than the decline in lung function over a year, which correlates with clinical outcomes. The decline of DPA, like the reduction in the daily step count, may become a biomarker of disease progression. |
| Interstitial Lung Disease |
| 1160 | Pulmonary fibrosis in non-mutation carriers of families with short telomere syndrome gene mutations
Joanne J van der Vis, Jasper J van der Smagt, Aernoud A van Batenburg, Roel Goldschmeding, H Wouter van Es, Jan C Grutters, Coline H M van Moorsel
10.1111/resp.14145
We present five patients with familial pulmonary fibrosis without carrying the familial telomere-related gene (TRG) mutation. This shows that increased risk for disease may be induced by inheritance of short telomeres. It implies that, in predictive genetic testing, absence of TRG mutation does not exclude the risk for disease. |
| Pulmonary Vascular Disease |
| 1171 | Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry
Katherine Kearney, Joshua Gold, Carolyn Corrigan, Kumud Dhital, David Boshell, David Haydock, David McGiffin, Michael Wilson, Nicholas Collins, Rachael Cordina, Nathan Dwyer, John Feenstra, Melanie Lavender, Jeremy Wrobel, Helen Whitford, Trevor Williams, Dominic Keating, Ken Whyte, Tanya McWilliams, Anne Keogh, Geoff Strange, Eugene Kotlyar, James Anderson, Edmund MT Lau
10.1111/resp.14162
Chronic thromboembolic pulmonary hypertension (CTEPH) is increasingly recognized as a prevalent cause of pulmonary hypertension, potentially curable with pulmonary endarterectomy (PEA) surgery. This analysis demonstrates that Australian and New Zealand patients display similar long-term survival outcomes as internationally reported data. Strategies for improving access for Australian and New Zealand patients to PEA are an important step for advancing treatment of CTEPH in this region. |
| Respiratory Infections |
| 1181 |
Air pollution and the pandemic: Long-term PM2.5 exposure and disease severity in COVID-19 patients
Angelico Mendy, Xiao Wu, Jason L Keller, Cecily S Fassler, Senu Apewokin, Tesfaye B Mersha, Changchun Xie, Susan M Pinney
10.1111/resp.14140
We examined the association between long-term exposure to particulate matter ≤2.5 μm (PM2.5) and coronavirus disease 2019 (COVID-19) outcomes in 14,783 COVID-19 patients diagnosed at the University of Cincinnati Health System. Our results suggested that a 1-μg/m3 increase in annual average PM2.5 between 2009 and 2018 was associated with 14%–18% higher odds of hospitalization for COVID-19.Air Pollution and the Pandemic: Long-term PM2.5 exposure and disease severity in COVID-19 patients |
| LETTERS FROM ASIA-PACIFIC AND BEYOND |
| 1188 |
Leading women in respiratory medicine: Letter from Japan
|
| 1190 | Letter from Spain
Marcelo Rázquin Arias MD, Paula Sol Ventura Wichner PhD, MD, Alejandro López-Escobar PhD, MD, Alvaro Díaz-Conradi PhD, MD, Zarife Daoud Pérez MD
10.1111/resp.14178 |
| 1192 | Letter from Spain: High-flow nasal oxygen—‘Go with the flow’
Silvia Suárez-Díaz MD, Andrés M Ortiz-Reyes MD, Juan Valdés-Bécares MD, Sara Fuente-Cosío MD, Antía Pérez-Piñeiro MD, Julia Lobo-García MD, César Gallo-Álvaro MD, María Gallego-Villalobos MD, Juan Miguel Manrique-Pérez MD, Sandra Rodríguez-Rodríguez MD, Rocío Arceo-Solís MD, Susana Suárez-Fernández MD, Iván Suárez-Pedreira MD, María Hernando-Gómez MD, Manuel Ricardo Rodríguez-Seoane MD, Joaquín Llorente-García MD, Vanesa Díaz-Fernández MD, Samuel Puente-Fernández MD, Cristina Elena Ramírez-Baum MD, Joaquín Alfonso-Megido MD, PhD
10.1111/resp.14177 |
